author-photo

Laura A. Bruins

Mayo Clinic

18

Papers

42

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Abstract 2209: Characterization of underlying genomic features among African ancestry populations diagnosed with chronic lymphocytic leukemia

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 884: Tumor mutational load derived from recurrently mutated genes in chronic lymphocytic leukemia (CLL) predicts time-to-first treatment in high-count monoclonal B-cell lymphocytosis (HC MBL)

2021 Epidemiology
Show All
- Source
- Cite
- Save
Citations (0)
Proteasome subunits differentially control Myeloma cell viability and proteasome inhibitor sensitivity.

2020 Molecular Cancer Research
Show All
- Source
- Cite
- Save
Citations (8)
Direct to Drug" screening as a precision medicine tool in multiple myeloma.

2020 Blood Cancer Journal
Show All
- Source
- Cite
- Save
Citations (9)
Ex vivo sensitivity to venetoclax is predictive of clinical activity

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
The contribution of proteasome subunits to Myeloma cell viability and proteasome inhibitor sensitivity

2019 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Identification of PIKfyve kinase as a target in multiple myeloma

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (6)
Integrative Analysis of FISH, Transcriptomics and Mutational Status Predicts Responsiveness to Novel Agents in Multiple Myeloma

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)
IKZF1/3 and CRL4-CRBN E3 ubiquitin ligase mutations and IMiD resistance in multiple myeloma

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (11)
The Contribution of Proteasome Subunits to Myeloma Cell Viability and Proteasome Inhibitor Sensitivity

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)